Sigma-Aldrich Posts 5 Percent Revenue Growth for Q4 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported that its fourth-quarter revenues increased 5 percent, or 3 percent organically, but it fell short of Wall Street's expectations.

The St. Louis-based research and chemical products firm reported total revenues of $610 million for the three-month period ended Dec. 31, compared to $582 million for the fourth quarter of 2010. Analysts, on average, had expected revenues of $626.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.